Loading…
Lobbying Spend
—
Filings
9
Firms Hired
1
Active Period
2013–2015
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
National Defense Authorization Act for Fiscal Year 2016
2015 · second_quarter · Firm: BUCHANAN INGERSOLL & ROONEY PC
Tricare reimbursement; VA clinical studies/FDA approval; efforts to regulate compounding pharmacies; HR 1735 The National Defense Authorization Act (NDAA) for Fiscal Year 2016, authorizing the budget for the Department of Defense and the national security programs of the Department of Energy (Sec. 714).
Client expense: — · Firm income: $40,000
Matched citations: HR 1735
National Defense Authorization Act for Fiscal Year 2016
2015 · second_quarter · Firm: BUCHANAN INGERSOLL & ROONEY PC
Tricare reimbursement; VA clinical studies/FDA approval; efforts to regulate compounding pharmacies; HR 1735 The National Defense Authorization Act (NDAA) for Fiscal Year 2016, authorizing the budget for the Department of Defense and the national security programs of the Department of Energy (Sec. 714).
Client expense: — · Firm income: $40,000
Matched citations: HR 1735
National Defense Authorization Act for Fiscal Year 2016
2015 · second_quarter · Firm: BUCHANAN INGERSOLL & ROONEY PC
Tricare reimbursement; basic insurance policies affecting the industry. HR 1735 The National Defense Authorization Act (NDAA) for Fiscal Year 2016, authorizing the budget for the Department of Defense and the national security programs of the Department of Energy (Sec. 714).
Client expense: — · Firm income: $40,000
Matched citations: HR 1735
An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2016 and setting forth the appropriate budgetary levels for fiscal years 2017 through 2025.
2015 · first_quarter · Firm: BUCHANAN INGERSOLL & ROONEY PC
Tricare reimbursement; basic insurance policies affecting the industry. S. Con Res 11, an original concurrent resolution setting forth the congressional budget for the United State Government for FY 2016 and setting forth appropriate budgetary levels for fiscal years 2017 through 2025.
Client expense: — · Firm income: $40,000
Matched citations: S. Con Res 11
An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2016 and setting forth the appropriate budgetary levels for fiscal years 2017 through 2025.
2015 · first_quarter · Firm: BUCHANAN INGERSOLL & ROONEY PC
Tricare reimbursement; VA clinical studies/FDA approval; efforts to regulate compounding pharmacies; S. Con Res 11, an original concurrent resolution setting forth the congressional budget for the United State Government for FY 2016 and setting forth appropriate budgetary levels for fiscal years 2017 through 2025.
Client expense: — · Firm income: $40,000
Matched citations: S. Con Res 11
An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2016 and setting forth the appropriate budgetary levels for fiscal years 2017 through 2025.
2015 · first_quarter · Firm: BUCHANAN INGERSOLL & ROONEY PC
Tricare reimbursement; VA clinical studies/FDA approval; efforts to regulate compounding pharmacies; S. Con Res 11, an original concurrent resolution setting forth the congressional budget for the United State Government for FY 2016 and setting forth appropriate budgetary levels for fiscal years 2017 through 2025.
Client expense: — · Firm income: $40,000
Matched citations: S. Con Res 11
An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2016 and setting forth the appropriate budgetary levels for fiscal years 2017 through 2025.
2015 · first_quarter · Firm: BUCHANAN INGERSOLL & ROONEY PC
Tricare reimbursement; VA clinical studies/FDA approval; efforts to regulate compounding pharmacies; Drug Quality and Security Act PL113-54; S. Con Res 11, an original concurrent resolution setting forth the congressional budget for the United State Government for FY 2016 and setting forth appropriate budgetary levels for fiscal years 2017 through 2025. Puerto Rico clinical trial request.
Client expense: — · Firm income: $40,000
Matched citations: S. Con Res 11
Source: Senate LDA